Abiomed Inc (NASDAQ:ABMD)

267.74
Delayed Data
As of Feb 16
 +6.70 / +2.57%
Today’s Change
110.61
Today|||52-Week Range
268.72
+42.86%
Year-to-Date
Abiomed's Extended FDA Nod for Impella Refines PCI Diagnosis
Feb 16 / Zacks.com - Paid Partner Content
Millipede to Aid Boston Scientific, LOTUS Relaunch Lag Ails
Feb 06 / Zacks.com - Paid Partner Content
Abiomed's Extended FDA Nod for Impella Boosts Women Health
Feb 14 / Zacks.com - Paid Partner Content
Mazor Robotics Hits 52-Week High: What's Driving the Stock?
Feb 05 / Zacks.com - Paid Partner Content
Quest Diagnostics Banks on Alliances, Long-Term View Solid
Feb 08 / Zacks.com - Paid Partner Content
Thermo Fisher Grows on New Buyouts Amid Tough Competition
Feb 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close261.04
Today’s open260.43
Day’s range260.01 - 268.72
Volume512,496
Average volume (3 months)362,264
Market cap$11.9B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+107.37%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+35.13%
P/E ratio134.5
Price/Sales12.56
Price/Book25.87

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+0.63+1.11%
WSTWest Pharmaceutical ...-0.89-1.01%
MASIMasimo Corp+0.74+0.86%
IARTIntegra LifeSciences...+0.83+1.61%
Data as of 4:01pm ET, 02/16/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.63
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts